HGHAX Fees and Costs — The Hartford Healthcare Fund, Class A
Data updated: 2026-09-29
The net expense ratio is 1.33%: a 0.88% management fee, a 0.25% 12b-1 fee plus 0.20% other expenses. This share class carries a maximum front-end sales load of 5.50%. In fiscal 2025 the fund paid $358K in broker commissions, 0.0411% of average net assets, and portfolio turnover was 23%.
HGHAX Fees and Expenses
Annual operating expenses and sales charges of HGHAX. Prospectus, as of October 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.88% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.20% |
| Gross expense ratio | 1.33% |
| Fee waiver | — |
| Net expense ratio | 1.33% |
| Sales charges | |
|---|---|
| Max front load | 5.50% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
HGHAX Costs Over Time
On $10,000 invested in HGHAX, assuming 5% a year before costs, total costs come to $1,506 over 5 years, cutting the return by 2.60% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $550 | $550 | $550 |
| Fund expenses (net expense ratio 1.33%) | $132 | $410 | $709 |
| Trading costs (broker commissions) | $4 | $13 | $22 |
| Lost growth on money paid in costs | $28 | $108 | $226 |
| Total costs | $714 | $1,081 | $1,506 |
| Value after costs | $9,786 | $10,496 | $11,256 |
| Impact on return, per year | 7.14% | 3.37% | 2.60% |
HGHAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0411%
- Total broker commissions: $358K
- Bought from dealers (principal trades, not a cost): $361.7M
- Portfolio turnover (prospectus): 23%
- Securities on loan, average value: $3.2M
- Net income from securities lending: $38K (0.004% of average net assets)
HGHAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley & Co. LLC | $62K | 22.30% |
| BTIG, LLC | $62K | 22.09% |
| Goldman Sachs & Co. LLC | $31K | 11.02% |
| RBC Capital Markets, LLC | $27K | 9.54% |
| UBS Securities LLC | $22K | 7.76% |
| J.P. Morgan Securities LLC | $21K | 7.34% |
| TD Securities (USA) LLC | $16K | 5.61% |
| Jefferies LLC | $15K | 5.28% |
| Mizuho Securities USA LLC | $13K | 4.66% |
| Citigroup Global Markets Inc. | $12K | 4.40% |
HGHAX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| State Street Bank and Trust Company | $337.7M | 93.37% |
| Jefferies LLC | $8.8M | 2.44% |
| J.P. Morgan Securities LLC | $7.8M | 2.17% |
| Leerink Partners LLC | $3.1M | 0.84% |
| Goldman Sachs & Co. LLC | $1.9M | 0.52% |
| BofA Securities, Inc. | $1.4M | 0.39% |
| Morgan Stanley & Co. LLC | $944K | 0.26% |
The Hartford Healthcare Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| HGHFX | Class F | 0.94% | none |
| HGHVX | Class R6 | 0.94% | none |
| HGHIX | Class I | 1.05% | none |
| HGHYX | Class Y | 1.05% | none |
| HGHTX | Class R5 | 1.06% | none |
| HGHAX | Class A | 1.33% | 5.50% |
| HGHSX | Class R4 | 1.35% | none |
| HGHRX | Class R3 | 1.66% | none |
| HGHCX | Class C | 2.12% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.